AI
AI: an early warning system for patient safety
November 3, 2026AI, Cardiology, Diabetes, Diagnostics, Obesity, Pharmacy, chronic disease, chronic pain, pharmacovigilance
By Sanjeev Sachdeva Safeguarding patient health is the foremost responsibility of the pharmaceutical sector. While every medicine undergoes rigorous clinical …
Charity commits £800,000 to AI research into late breast cancer recurrence
October 28, 2026AI, Immunology, Oncology, breast cancer, cytology, oncology, research and development
Breast Cancer Now is investing £800,000 in two research projects using artificial intelligence to investigate why oestrogen receptor-positive (ER-positive) breast …
Aiforia deal to expand access to pathology AI
October 22, 2026AI, Corporate, Devices, Hospital Management, commercial agreements, digital pathology
Aiforia has signed a commercial agreement with PathAI to make its artificial intelligence (AI) solutions for digital pathology available to …
Cori Clinical raises US$4m to expand AI platform for clinical trial design
October 14, 2026AI, Data Capture, Pharmacy, clinical data, clinical trial design, regulatory affairs
Cori Clinical has raised US$4m in a seed funding round to expand its AI platform for clinical trial design and …
Agentic commercial: how AI creates dialogue with HCPs and patients to help medicines reach them faster
October 11, 2026Licenses/Quality Standards, Marketing, Sales & Marketing Training AI, Devices, Diagnostics, Hospital Management, Pharmacy, biopharma, medical adoption, pharmaceutical
By Chris Moore Commercial engagement in biopharma used to centre largely on direct conversations between sales reps and physicians or …
Liverpool launches £20m lab for infectious disease drug discovery
September 16, 2026AI, human organoids, infectious disease drug discovery lab, liverpool, robotics
A new £20m high-security laboratory using robotics, artificial intelligence (AI) and human organoids to accelerate drug and vaccine development for …
AI in pharma: From lab development to patient impact
September 5, 2026AI, Cancer, Immunology, Merck, Vaccine, Virology, personalised medicine, pharma
In the decade to 2025, AI use in vaccine development has increased markedly but is the boom in research translating …
Bioptimus partners with Cancer Research Horizons to expand AI cancer data set
August 27, 2026AI, Bioptimus, Cancer Research Horizons, Cancer Research UK, colorectal cancer
Bioptimus has partnered with Cancer Research Horizons, the innovation arm of Cancer Research UK, to give the AI biotechnology company …
Sofinnova and AWS collaborate on AI tools for life sciences
June 10, 2026Research and Development AI, Amazon Web Services (AWS), Sofinnova
Sofinnova Partners has announced a collaboration with Amazon Web Services (AWS) aimed at expanding the use of AI across life …
Practical AI toolkit launched to help manufacturers cut through complexity
May 6, 2026Manufacturing and Production AI, Made Smarter
A new guide from Made Smarter is helping manufacturers cut through the noise around AI and focus on what actually …
Bramacare launches new AI platform to improve eating disorder care
March 31, 2026Market & Product Development AI, Bramacare, eating disorders
Bramacare has launched an AI-enabled platform designed to aid eating disorder and rehabilitation services, the first of its kind in …
Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory
March 25, 2026Research and Development AI, NVIDIA, Roche
Roche has expanded its global AI infrastructure with a NVIDIA AI factory, adding 2,176 high-performance graphics processing units (GPUs) across …
Cellbyte raises $2.75m to fund pharma drug launch platform
November 27, 2025Product launch AI, Cellbyte, biotech
Cellbyte has announced that it has raised $2.75m in seed funding for the streamlining of pharmaceutical drug launches. The complexity …
MultiOmic Health and BIO4 Campus sign collaborative Memorandum of Understanding
September 8, 2025Medical Communications, Research and Development AI, BIO4 Campus, Memorandum of Understanding, MultiOmic Health, biotech
MultiOmic Health (MOH), an artificial intelligence (AI)-enabled precision medicine biotechnology company and BIO4 Campus (BIO4), a biotechnology and life sciences …
Sanome’s AI tool gains certification for early detection of hospital infections
August 7, 2025Business Services, Research and Development AI, Devices, Infections and infestations, Medicines and Healthcare products Regulatory Agency, NHS, Sanome, hospital-acquired infections
Sanome’s MEMORI, an artificial intelligence (AI) medical device that can predict hospital-acquired infections up to 72 hours before they present, …
Latest content
Recruitment experts hired in search for new CGT Catapult chief
Envirogen secures place on NHS Scotland reverse osmosis framework
